{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:05:42Z","timestamp":1791335142563,"version":"4.3.1"},"reference-count":40,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"DOI":"10.25122\/jml-2023-0090","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T03:23:56Z","timestamp":1715397836000},"page":"1357-1363","source":"Crossref","is-referenced-by-count":11,"title":["Ameliorative effect of nebivolol in doxorubicin-induced cardiotoxicity"],"prefix":"10.25122","volume":"16","author":[{"given":"Najah Rayish","family":"Hadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmacology and Therapeutics, Faculty of Pharmacy, University of Kufa, Najaf, Iraq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Al-Amir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Directorate of Najaf Health, Najaf, Iraq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Janabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Kufa, Najaf, Iraq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","published-online":{"date-parts":[[2023,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/9781118683484.ch19","article-title":"Cardiovascular toxicology and its evaluation","author":"Gad SC","year":"2015","unstructured":"1. Gad SC Cardiovascular toxicology and its evaluation Mammalian Toxicology 201542552 10.1002\/9781118683484.ch19","journal-title":"Mammalian Toxicology"},{"issue":"10","key":"ref2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3238\/arztebl.2014.0161","article-title":"Cardiotoxicity and oncological treatments","volume":"111","author":"Schlitt A Jordan K Vordermark D Schwamborn J","year":"2014","unstructured":"2. Schlitt A Jordan K Vordermark D Schwamborn J  Cardiotoxicity and oncological treatments Dtsch Arztebl Int 2014111101618 10.3238\/arztebl.2014.0161","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"ref3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/imr.12581","article-title":"Danger signals: Chemotherapy enhancers?","volume":"280","author":"Rivera Vargas T Apetoh L","year":"2017","unstructured":"3. Rivera Vargas T Apetoh L Danger signals: Chemotherapy enhancers? Immunol Rev 20172801175193 10.1111\/imr.12581","journal-title":"Immunol Rev"},{"issue":"3","key":"ref4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/eci.12589","article-title":"Update on cardiotoxicity of anti-cancer treatments","volume":"46","author":"Rosa GM Gigli L Tagliasacchi MI Di Iorio C","year":"2016","unstructured":"4. Rosa GM Gigli L Tagliasacchi MI Di Iorio C  Update on cardiotoxicity of anti-cancer treatments Eur J Clin Invest 201646326484 10.1111\/eci.12589","journal-title":"Eur J Clin Invest"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","article-title":"Molecular mechanism of doxorubicin-induced cardiomyopathy-An update","volume":"818","author":"Renu K V G A P B TP Arunachalam S","year":"2018","unstructured":"5. Renu K V G A P B TP Arunachalam S Molecular mechanism of doxorubicin-induced cardiomyopathy-An update Eur J Pharmacol 2018818241253 10.1016\/j.ejphar.2017.10.043","journal-title":"Eur J Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/jphp.12539.","article-title":"Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism","volume":"68","author":"Meredith A-M Dass CR","year":"2016","unstructured":"6. Meredith A-M Dass CR Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism J Pharm Pharmacol 20166872941 10.1111\/jphp.12539.","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti G Menna P Salvatorelli E Cairo G Gianni L","year":"2004","unstructured":"7. Minotti G Menna P Salvatorelli E Cairo G Gianni L Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity Pharmacol Rev 2004 Jun562185229 10.1124\/pr.56.2.6","journal-title":"Pharmacol Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0076-6879(05)91004-5","article-title":"The liposomal formulation of doxorubicin","volume":"391","author":"Abraham SA Waterhouse DN Mayer LD Cullis PR","year":"2005","unstructured":"8. Abraham SA Waterhouse DN Mayer LD Cullis PR  The liposomal formulation of doxorubicin Methods Enzymol 20053917197 10.1016\/S0076-6879(05)91004-5","journal-title":"Methods Enzymol"},{"issue":"13","key":"ref9","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.2174\/092986709788186228","article-title":"New developments in anthracycline-induced cardiotoxicity","volume":"16","author":"Mordente A Meucci E Silvestrini A Martorana GE Giardina B","year":"2009","unstructured":"9. Mordente A Meucci E Silvestrini A Martorana GE Giardina B New developments in anthracycline-induced cardiotoxicity Curr Med Chem 20091613165672 10.2174\/092986709788186228","journal-title":"Curr Med Chem"},{"issue":"2","key":"ref10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3233\/JAD-2011-111391","article-title":"Mitochondria-targeted antioxidants as promising drugs for treatment of age-related brain diseases","volume":"28","author":"Skulachev VP","year":"2012","unstructured":"10. Skulachev VP Mitochondria-targeted antioxidants as promising drugs for treatment of age-related brain diseases J Alzheimers Dis 20122822839 10.3233\/JAD-2011-111391","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"ref11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1124\/mol.119.115725","article-title":"Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring","volume":"96","author":"Wenningmann N Knapp M Ande A Vaidya TR Ait-Oudhia S","year":"2019","unstructured":"11. Wenningmann N Knapp M Ande A Vaidya TR Ait-Oudhia S Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring Mol Pharmacol 2019962219232 10.1124\/mol.119.115725","journal-title":"Mol Pharmacol"},{"issue":"3","key":"ref12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2174\/1570161112666140423223529","article-title":"Cardiovascular effects of current and future anti-obesity drugs","volume":"12","author":"Comerma-Steffensen S Grann M Andersen CU Rungby J Simonsen U","year":"2014","unstructured":"12. Comerma-Steffensen S Grann M Andersen CU Rungby J Simonsen U Cardiovascular effects of current and future anti-obesity drugs Curr Vasc Pharmacol 2014123493504 10.2174\/1570161112666140423223529","journal-title":"Curr Vasc Pharmacol"},{"issue":"3","key":"ref13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/bcpt.13248","article-title":"Nebivolol in the treatment of arterial hypertension","volume":"125","author":"Olawi N Kr\u00fcger M Grimm D Infanger M Wehland M","year":"2019","unstructured":"13. Olawi N Kr\u00fcger M Grimm D Infanger M Wehland M Nebivolol in the treatment of arterial hypertension Basic Clin Pharmacol Toxicol 20191253189201 10.1111\/bcpt.13248","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"ref14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1742-7843.2012.00911.x","article-title":"Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension","volume":"111","author":"Zepeda RJ Castillo R Rodrigo R Prieto JC","year":"2012","unstructured":"14. Zepeda RJ Castillo R Rodrigo R Prieto JC  Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension Basic Clin Pharmacol Toxicol 2012111530916 10.1111\/j.1742-7843.2012.00911.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"ref15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/HJH.0000000000000024","article-title":"Nebivolol induces, via \u03b23 adrenergic receptor, lipolysis, uncoupling protein 1, and reduction of lipid droplet size in human adipocytes","volume":"32","author":"Bordicchia M Pocognoli A D'Anzeo M Siquini W","year":"2014","unstructured":"15. Bordicchia M Pocognoli A D'Anzeo M Siquini W  Nebivolol induces, via \u03b23 adrenergic receptor, lipolysis, uncoupling protein 1, and reduction of lipid droplet size in human adipocytes J Hypertens 201432238996 10.1097\/HJH.0000000000000024","journal-title":"J Hypertens"},{"issue":"2","key":"ref16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/FJC.0000000000000444","article-title":"Targeting \u03b23-Adrenergic Receptors in the Heart: Selective Agonism and \u03b2-Blockade","volume":"69","author":"Cannavo A Koch WJ","year":"2017","unstructured":"16. Cannavo A Koch WJ Targeting \u03b23-Adrenergic Receptors in the Heart: Selective Agonism and \u03b2-Blockade J Cardiovasc Pharmacol 20176927178 10.1097\/FJC.0000000000000444","journal-title":"J Cardiovasc Pharmacol"},{"issue":"13","key":"ref17","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1016\/j.ejca.2013.04.030","article-title":"Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis","volume":"49","author":"Kalam K Marwick TH","year":"2013","unstructured":"17. Kalam K Marwick TH Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis Eur J Cancer 2013491329009 10.1016\/j.ejca.2013.04.030","journal-title":"Eur J Cancer"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.cjca.2014.03.003","article-title":"Nebivolol: vasodilator properties and evidence for relevance in treatment of cardiovascular disease","volume":"30","author":"Howlett JG","year":"2014","unstructured":"18. Howlett JG Nebivolol: vasodilator properties and evidence for relevance in treatment of cardiovascular disease Can J Cardiol 2014305 SupplS2937 10.1016\/j.cjca.2014.03.003","journal-title":"Can J Cardiol"},{"issue":"3","key":"ref19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/biof.1823","article-title":"The cardioprotective effects of nano-curcumin against doxorubicin-induced cardiotoxicity: A systematic review","volume":"48","author":"Moutabian H Ghahramani-Asl R Mortezazadeh T Laripour R","year":"2022","unstructured":"19. Moutabian H Ghahramani-Asl R Mortezazadeh T Laripour R  The cardioprotective effects of nano-curcumin against doxorubicin-induced cardiotoxicity: A systematic review BioFactors 2022483 597610 10.1002\/biof.1823","journal-title":"BioFactors"},{"issue":"5","key":"ref20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","article-title":"Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management","volume":"49","author":"Takemura G Fujiwara H","year":"2007","unstructured":"20. Takemura G Fujiwara H Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management Prog Cardiovasc Dis 200749533052 10.1016\/j.pcad.2006.10.002","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"ref21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","article-title":"The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin","volume":"20","author":"Quagliariello V De Laurentiis M Rea D Barbieri A","year":"2021","unstructured":"21. Quagliariello V De Laurentiis M Rea D Barbieri A  The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin Cardiovasc Diabetol 2021201150 10.1186\/s12933-021-01346-y","journal-title":"Cardiovasc Diabetol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"120343","DOI":"10.1016\/j.talanta.2019.120343","article-title":"Raman spectroscopy: A novel experimental approach to evaluating cisplatin induced tissue damage","volume":"207","author":"Yay A Onses MS Sahmetlioglu E Ceyhan A","year":"2020","unstructured":"22. Yay A Onses MS Sahmetlioglu E Ceyhan A  Raman spectroscopy: A novel experimental approach to evaluating cisplatin induced tissue damage Talanta 2020207120343 10.1016\/j.talanta.2019.120343","journal-title":"Talanta"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy","volume":"93","author":"P\u00e9rez-Herrero E Fern\u00e1ndez-Medarde A","year":"2015","unstructured":"23. P\u00e9rez-Herrero E Fern\u00e1ndez-Medarde A Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy Eur J Pharm Biopharm 2015935279 10.1016\/j.ejpb.2015.03.018","journal-title":"Eur J Pharm Biopharm"},{"issue":"7","key":"ref24","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: the cytokine hypothesis revisited","volume":"116","author":"Mann DL","year":"2015","unstructured":"24. Mann DL Innate immunity and the failing heart: the cytokine hypothesis revisited Circ Res 20151167125468 10.1161\/CIRCRESAHA.116.302317","journal-title":"Circ Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"755862","DOI":"10.3389\/fimmu.2021.755862","article-title":"Co-Exposure of Cardiomyocytes to IFN-\u03b3 and TNF-\u03b1 Induces Mitochondrial Dysfunction and Nitro-Oxidative Stress: Implications for the Pathogenesis of Chronic Chagas Disease Cardiomyopathy","volume":"12","author":"Nunes JPS Andrieux P Brochet P Almeida RR","year":"2021","unstructured":"25. Nunes JPS Andrieux P Brochet P Almeida RR  Co-Exposure of Cardiomyocytes to IFN-\u03b3 and TNF-\u03b1 Induces Mitochondrial Dysfunction and Nitro-Oxidative Stress: Implications for the Pathogenesis of Chronic Chagas Disease Cardiomyopathy Front Immunol 202112755862 10.3389\/fimmu.2021.755862","journal-title":"Front Immunol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cbi.2019.02.028","article-title":"\u03b2-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB2) receptors in rats","volume":"304","author":"Meeran MFN Al Taee H Azimullah S Tariq S","year":"2019","unstructured":"26. Meeran MFN Al Taee H Azimullah S Tariq S  \u03b2-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB2) receptors in rats Chem Biol Interact 2019304158167 10.1016\/j.cbi.2019.02.028","journal-title":"Chem Biol Interact"},{"issue":"5","key":"ref27","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/1440-1681.13481","article-title":"Nebivolol protects against cyclophosphamide-induced nephrotoxicity through modulation of oxidative stress, inflammation, and apoptosis","volume":"48","author":"Wanas H El-Shabrawy M Mishriki A Attia H","year":"2021","unstructured":"27. Wanas H El-Shabrawy M Mishriki A Attia H  Nebivolol protects against cyclophosphamide-induced nephrotoxicity through modulation of oxidative stress, inflammation, and apoptosis Clin Exp Pharmacol Physiol 2021485811819 10.1111\/1440-1681.13481","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"ref28","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.5114\/aoms.2018.79008","article-title":"Protective effect of nebivolol on doxorubicin-induced cardiotoxicity in rats","volume":"14","author":"Mohamed EA Kassem HH","year":"2018","unstructured":"28. Mohamed EA Kassem HH Protective effect of nebivolol on doxorubicin-induced cardiotoxicity in rats Arch Med Sci 201814614501458 10.5114\/aoms.2018.79008","journal-title":"Arch Med Sci"},{"issue":"1","key":"ref29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/s1734-1140(10)70245-0","article-title":"Does nebivolol influence serum concentrations of proinflammatory cytokines in hypertensive (SHR) and normotensive (WKY) rats?","volume":"62","author":"G\u00f3rska D Dudarewicz M Czarnecka E Andrzejczak D","year":"2010","unstructured":"29. G\u00f3rska D Dudarewicz M Czarnecka E Andrzejczak D Does nebivolol influence serum concentrations of proinflammatory cytokines in hypertensive (SHR) and normotensive (WKY) rats? Pharmacol Rep 20106218694 10.1016\/s1734-1140(10)70245-0","journal-title":"Pharmacol Rep"},{"issue":"7","key":"ref30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/jir.2006.0161","article-title":"Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death","volume":"27","author":"Chiosi E Spina A Sorrentino A Romano M","year":"2007","unstructured":"30. Chiosi E Spina A Sorrentino A Romano M  Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death J Interferon Cytokine Res 200727758997 10.1089\/jir.2006.0161","journal-title":"J Interferon Cytokine Res"},{"issue":"3","key":"ref31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.nephro.2016.01.011.","article-title":"Recent advances in the treatment of renal diseases with nebivolol: A literature review","volume":"12","author":"Shamekhi Amiri F","year":"2016","unstructured":"31. Shamekhi Amiri F Recent advances in the treatment of renal diseases with nebivolol: A literature review Nephrol Ther 20161231408 10.1016\/j.nephro.2016.01.011.","journal-title":"Nephrol Ther"},{"issue":"6","key":"ref32","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/jhh.2017.8","article-title":"Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage","volume":"31","author":"Coats A Jain S","year":"2017","unstructured":"32. Coats A Jain S Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage J Hum Hypertens 2017316376381 10.1038\/jhh.2017.8","journal-title":"J Hum Hypertens"},{"issue":"4","key":"ref33","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/clc.21013.","article-title":"Does nebivolol prevent contrast-induced nephropathy in humans?","volume":"35","author":"G\u00fcnebakmaz O Kaya MG Koc F Akpek M","year":"2012","unstructured":"33. G\u00fcnebakmaz O Kaya MG Koc F Akpek M  Does nebivolol prevent contrast-induced nephropathy in humans? Clin Cardiol 20123542504 10.1002\/clc.21013.","journal-title":"Clin Cardiol"},{"issue":"4","key":"ref34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3322\/caac.21341","article-title":"Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management","volume":"66","author":"Curigliano G Cardinale D Dent S Criscitiello C","year":"2016","unstructured":"34. Curigliano G Cardinale D Dent S Criscitiello C  Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management CA Cancer J Clin 201666430925 10.3322\/caac.21341","journal-title":"CA Cancer J Clin"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.etap.2018.01.011","article-title":"Protective role of nebivolol in cadmium-induced hepatotoxicity via downregulation of oxidative stress, apoptosis and inflammatory pathways","volume":"58","author":"Refaie MMM El-Hussieny M Zenhom NM","year":"2018","unstructured":"35. Refaie MMM El-Hussieny M Zenhom NM Protective role of nebivolol in cadmium-induced hepatotoxicity via downregulation of oxidative stress, apoptosis and inflammatory pathways Environ Toxicol Pharmacol 201858212219 10.1016\/j.etap.2018.01.011","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"ref36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pnpbp.2011.08.011","article-title":"The anti-oxidant and anti-apoptotic effects of nebivolol and zofenopril in a model of cerebral ischemia\/reperfusion in rats","volume":"36","author":"Uzar E Acar A Evliyao\u011flu O F\u0131rat U","year":"2012","unstructured":"36. Uzar E Acar A Evliyao\u011flu O F\u0131rat U  The anti-oxidant and anti-apoptotic effects of nebivolol and zofenopril in a model of cerebral ischemia\/reperfusion in rats Prog Neuropsychopharmacol Biol Psychiatry 2012361228 10.1016\/j.pnpbp.2011.08.011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"9","key":"ref37","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1080\/08860220802353900.","article-title":"Nebivolol reduces experimentally induced warm renal ischemia reperfusion injury in rats","volume":"30","author":"Gandhi C Zalawadia R Balaraman R","year":"2008","unstructured":"37. Gandhi C Zalawadia R Balaraman R Nebivolol reduces experimentally induced warm renal ischemia reperfusion injury in rats Ren Fail 200830992130 10.1080\/08860220802353900.","journal-title":"Ren Fail"},{"issue":"1","key":"ref38","first-page":"86","article-title":"Nebivolol and chrysin protect the liver against ischemia\/reperfusion-induced injury in rats","volume":"4","author":"Mizar SM Omar HA El Sherbiny GA El-moselhy MA","year":"2015","unstructured":"38. Mizar SM Omar HA El Sherbiny GA El-moselhy MA Nebivolol and chrysin protect the liver against ischemia\/reperfusion-induced injury in rats Beni-Suef Univ J Basic Appl Sci 2015418692","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"3","key":"ref39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/1687-4625.195889","article-title":"Protective effects of nebivolol on acetic acid-induced ulcerative colitis in rats","volume":"22","author":"Labib DAA Shaker OG Elfarouk LO","year":"2016","unstructured":"39. Labib DAA Shaker OG Elfarouk LO Protective effects of nebivolol on acetic acid-induced ulcerative colitis in rats Kasr Al Ainy Med J 201622399 10.4103\/1687-4625.195889","journal-title":"Kasr Al Ainy Med J"},{"issue":"4","key":"ref40","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1253\/circj.72.660","article-title":"The effects of nebivolol on apoptosis in a rat infarct model","volume":"72","author":"Mercanoglu G Safran N Gungor M Pamukcu B","year":"2008","unstructured":"40. Mercanoglu G Safran N Gungor M Pamukcu B  The effects of nebivolol on apoptosis in a rat infarct model Circ J 200872466070 10.1253\/circj.72.660","journal-title":"Circ J"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2023\/issue-9-2023\/original-article-issue-9-2023\/ameliorative-effect-of-nebivolol-in-doxorubicin-induced-cardiotoxicity\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T03:25:02Z","timestamp":1715397902000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2023\/issue-9-2023\/original-article-issue-9-2023\/ameliorative-effect-of-nebivolol-in-doxorubicin-induced-cardiotoxicity\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["JMedLife-16-1357"],"URL":"https:\/\/doi.org\/10.25122\/jml-2023-0090","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}